Heron Therapeutics is trading 5.28% higher at $0.35 in pre-market on October 7, 2026, with no fresh company-specific announcement identified to explain the move.
- Shares fell 10.35% to $0.33 on October 6, according to the supplied price context.
- The official news-release page lists no October 6 or 7 release; its latest listed release is dated August 10.
- Major indices are nearly flat and futures modestly lower; available evidence does not establish a broader-market reason for the rebound.